A common inquiry in international intellectual property law is whether an invention built upon an existing technological principle can be granted a new patent if its core logical framework remains unchanged. Across major global jurisdictions—including the United States Patent and Trademark Office (USPTO), the European Patent Office (EPO), and the Japan Patent Office (JPO)—the answer is unequivocally affirmative: an improvement upon an existing technology is fully eligible for an independent patent, provided it meets the statutory standard of non-obviousness or inventive step. However, securing an improvement patent does not automatically grant the inventor the absolute right to commercialize it without navigating foreign foundational rights.
The Global Standard: Granting Improvement Patents via Non-Obviousness
International patent treaties, such as the WTO TRIPS Agreement, establish harmonized criteria for patentability: novelty, inventive step (non-obviousness), and industrial applicability. Even if an invention shares its foundational logic or scientific principle with a pre-existing patent, it qualifies for its own patent if the modifications yield significantly superior performance, resolve long-standing technical drawbacks, or achieve unexpected technical results. Patent offices evaluate the specific structural claims of an application rather than broad abstract principles, meaning an upgraded process or optimized chemical compound constitutes a distinct piece of intellectual property.
The Crucial Distinction: “Right to Exclude” versus “Right to Practice”
The global enforcement of improvement patents introduces a fundamental doctrine in patent jurisprudence: a patent grants a negative right, not a positive one. In Anglo-American and European legal systems, a patent grants the holder a Right to Exclude others from making, using, or selling the patented technology. It does not grant an inherent Right to Practice the technology if doing so infringes upon a broader, underlying patent.
When an improved patent necessarily incorporates the foundational technology of a prior, active patent, the improvement is legally classified as a “dependent patent.” Even though the inventor of an improvement holds a valid, government-granted patent, producing or selling the improved product without a license from the foundational patent holder constitutes actionable patent infringement in courts worldwide.
Global Commercialization and Cross-Licensing Strategies
Because dependent patent relationships exist universally, multinational corporations—such as tech giants in mobile communications, semiconductors, and pharmaceuticals—frequently find themselves in commercial deadlocks where foundational patent holders and improvement patent holders need each other’s technology. To resolve these impasses without costly global litigation, international businesses rely on cross-licensing agreements.
Foundational patent holders need the superior performance offered by improvement patents to remain competitive in modern markets, while improvement patent holders need access to the core logic. Under a cross-licensing framework, both parties grant each other reciprocal rights to practice their respective patents, often balancing valuation differences through royalty payments.
Conclusion
Across all major international legal regimes, an invention that refines, strengthens, or builds upon an existing principle can successfully obtain its own independent patent protection. However, international patent law strictly maintains the doctrine of dependent patents, ensuring that securing an improvement patent does not override prior foundational rights. This dual mechanism ensures a balanced global innovation ecosystem: it rewards latecomer innovators for enhancing existing technology while protecting original pioneers, driving competitors toward mutual cross-licensing and collaborative market expansion.
If you enjoyed this piece:
Explore the “You Have Already Agreed” collection
Discover more from the Abstract collection
Leave a Reply